Final results of a Spanish Lung Cancer Group (SLCG) phase II study of paclitaxel (PAC) plus gemcitabine (GEM) in locally advanced and metastatic non-small cell lung cancer (NSCLC).

被引：0
|
作者：
Isla, D [1 ]
González-Larriba, JL [1 ]
Felip, E [1 ]
Camps, C [1 ]
Artal, A [1 ]
Carrato, A [1 ]
Azagra, P [1 ]
Alberola, V [1 ]
Massutti, B [1 ]
Rosell, R [1 ]
机构：
[1] Hosp Clin Lozano Blesa, Zaragoza, Spain
来源：
ANNALS OF ONCOLOGY | 2000年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
521P
引用
收藏
页码：114 / 114
页数：1
相关论文
共 50 条
  • [1] Sequential (S) chemotherapy (Ch) with gemcitabine (GEM) and paclitaxel (T) in advanced non-small cell lung cancer (NSCLC): A feasibility phase II study by the Spanish Lung Cancer Group (SLCG). Preliminary study
    Camps, C
    Carrato, A
    Gomez-Aldavari, J
    Gonzalez-Larriba, J
    Massuti, B
    Provencio, M
    Velasco, A
    Sirera, R
    Rosell, R
    LUNG CANCER, 2005, 49 : S240 - S240
  • [2] Phase II study of paclitaxel and gemcitabine in advanced non-small cell lung cancer (NSCLC).
    Lazaro, M
    Jorge, M
    Castellanos, J
    ANNALS OF ONCOLOGY, 2000, 11 : 109 - 109
  • [3] Carboplatin plus gemcitabine followed by weekly paclitaxel in advanced and metastatic non-small cell lung cancer (NSCLC): A phase II study
    Tjan-Heijnen, V
    Timmer-Bonte, J
    van der Drift, M
    van Leeuwen, F
    de Boo, T
    Wagenaar, M
    van Die, L
    Bussink, J
    LUNG CANCER, 2005, 49 : S272 - S272
  • [4] Gemcitabine in locally advanced and metastatic non-small cell lung cancer (NSCLC): The Central European phase II study
    Jassem, J
    Zatloukal, P
    Kanitz, E
    Magyar, P
    Krzakowski, M
    Pawlicki, M
    Petruzelka, L
    Chovan, L
    Pesek, M
    Krejcy, K
    ANNALS OF ONCOLOGY, 1998, 9 : 90 - 90
  • [5] Gemcitabine plus cisplatin in advanced non-small cell lung cancer (NSCLC): A phase II study
    Orlandi-Jorquera, L
    Orlandi, F
    Galaz, P
    Gamargo, C
    Salman, P
    Yanez, M
    ANNALS OF ONCOLOGY, 1998, 9 : 101 - 101
  • [6] Phase II study of vinorelbine (VNR) and gemcitabine (GEM) in advanced non-small cell lung cancer (NSCLC)
    Firvida, JL
    Rodriguez, R
    Sabin, P
    Castellanos, J
    Mata, JG
    Salgado, M
    Vazquez, S
    Lazaro, M
    Delgado, FM
    ANNALS OF ONCOLOGY, 1998, 9 : 97 - 97
  • [7] Gemcitabine (G) plus cisplatin (C) in advanced non-small cell lung cancer (NSCLC): Final phase II results.
    Casal, J
    Huidobro, G
    Grande, C
    Caeiro, M
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S68 - S68
  • [8] Phase II trial of paclitaxel plus gemcitabine in patients with locally advanced or metastatic non-small-cell lung cancer
    Isla, D
    Rosell, R
    Sánchez, JJ
    Carrato, A
    Felip, E
    Camps, C
    Artal, A
    González-Larriba, JL
    Azagra, P
    Alberola, J
    Martin, C
    Massutí, B
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (04) : 1071 - 1077
  • [9] Concurrent chemoradiotherapy with Gemcitabine for locally advanced non-small cell lung cancer (NSCLC): Preliminary results of a phase II study
    Athanasiou, E
    Cyrgias, G
    Boinis, K
    Samantas, E
    Christodoulidou, M
    Tamvaki, F
    Panoussaki, E
    ANNALS OF ONCOLOGY, 1998, 9 : 97 - 97
  • [10] Gemcitabine, ifosfamide and paclitaxel in advanced/metastatic non-small cell lung cancer patients: a phase II study
    Piantedosi, F. V.
    Caputo, F.
    Mazzarella, G.
    Gilli, M.
    Pontillo, A.
    D'Agostino, D.
    Campbell, S.
    Marsico, S. A.
    Bianco, A.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 61 (05) : 803 - 807
12345